BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19531004)

  • 1. Applications of cellular systems biology in breast cancer patient stratification and diagnostics.
    Critchley-Thorne RJ; Miller SM; Taylor DL; Lingle WL
    Comb Chem High Throughput Screen; 2009 Nov; 12(9):860-9. PubMed ID: 19531004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular systems biology profiling applied to cellular models of disease.
    Giuliano KA; Premkumar DR; Strock CJ; Johnston P; Taylor L
    Comb Chem High Throughput Screen; 2009 Nov; 12(9):838-48. PubMed ID: 19531002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplexed high content screening assays create a systems cell biology approach to drug discovery.
    Taylor DL; Giuliano KA
    Drug Discov Today; 2005; Suppl():13-8. PubMed ID: 23570162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systems Biology Approaches in Cancer Pathology.
    DeWard A; Critchley-Thorne RJ
    Methods Mol Biol; 2018; 1711():261-273. PubMed ID: 29344894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early safety assessment using cellular systems biology yields insights into mechanisms of action.
    Giuliano KA; Gough AH; Taylor DL; Vernetti LA; Johnston PA
    J Biomol Screen; 2010 Aug; 15(7):783-97. PubMed ID: 20639501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systems biology and genomics of breast cancer.
    Perou CM; Børresen-Dale AL
    Cold Spring Harb Perspect Biol; 2011 Feb; 3(2):. PubMed ID: 21047916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative system biology strategies for disease biomarker discovery.
    Zhang H; Hu H; Deng C; Chun Y; Zhou S; Huang F; Zhou Q
    Comb Chem High Throughput Screen; 2012 May; 15(4):286-98. PubMed ID: 22221061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction: Cancer Gene Networks.
    Clarke R
    Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation.
    Katsila T; Matsoukas MT; Patrinos GP; Kardamakis D
    OMICS; 2017 Aug; 21(8):429-439. PubMed ID: 28816643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies.
    Du W; Elemento O
    Oncogene; 2015 Jun; 34(25):3215-25. PubMed ID: 25220419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems pathology--taking molecular pathology into a new dimension.
    Faratian D; Clyde RG; Crawford JW; Harrison DJ
    Nat Rev Clin Oncol; 2009 Aug; 6(8):455-64. PubMed ID: 19581910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of systems biology in cancer immunotherapy: from target discovery to biomarkers of clinical outcome.
    Guhathakurta D; Sheikh NA; Meagher TC; Letarte S; Trager JB
    Expert Rev Clin Pharmacol; 2013 Jul; 6(4):387-401. PubMed ID: 23927667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpreting networks in systems biology.
    Arrell DK; Terzic A
    Clin Pharmacol Ther; 2013 May; 93(5):389-92. PubMed ID: 23511712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of proteomic technologies in breast cancer research.
    Mazur MG; Pyatchanina TV
    Exp Oncol; 2016 Sep; 38(3):146-57. PubMed ID: 27685521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights from Systems Biology in Physiological Studies: Learning from Context.
    Imenez Silva PH; Melo D; de Mendonça POR
    Cell Physiol Biochem; 2017; 42(3):939-951. PubMed ID: 28662523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer risk assessment: a non-invasive multiparametric approach to stratify patients by MMP-9 serum activity and RhoA expression patterns in circulating leucocytes.
    Golubnitschaja O; Yeghiazaryan K; Abraham JA; Schild HH; Costigliola V; Debald M; Kuhn W
    Amino Acids; 2017 Feb; 49(2):273-281. PubMed ID: 27812894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics and systems biology: application in drug discovery and development.
    Chakravarti B; Mallik B; Chakravarti DN
    Methods Mol Biol; 2010; 662():3-28. PubMed ID: 20824464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers.
    Bradford JR; Wappett M; Beran G; Logie A; Delpuech O; Brown H; Boros J; Camp NJ; McEwen R; Mazzola AM; D'Cruz C; Barry ST
    Oncotarget; 2016 Apr; 7(15):20773-87. PubMed ID: 26980748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular markers to predict the prognosis of breast cancer].
    Luque EH; Muñoz de Toro de Luque M; Romero Acuña L; Langhi M; Romero Acuña J
    Medicina (B Aires); 1993; 53(2):151-66. PubMed ID: 8295533
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.